{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:54:15Z","timestamp":1791615255154,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1053\/berh.1999.0082","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T21:49:59Z","timestamp":1027892999000},"page":"139-150","source":"Crossref","is-referenced-by-count":13,"title":["The anti-phospholipid antibody syndrome: clinical and serological aspects"],"prefix":"10.1053","volume":"14","author":[{"given":"Donato","family":"Alarc\u00f3n-Segovia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio R.","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/berh.1999.0082_RF1","first-page":"416","article-title":"Thrombosis in systemic lupus erythematosus despite circulating anticoagulants","volume":"62","author":"Bowie","year":"1963","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/berh.1999.0082_RF2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.7326\/0003-4819-62-5-907","article-title":"Peripheral vascular syndromes associated with systemic lupus erythematosus","volume":"62","author":"Alarc\u00f3n-Segovia","year":"1965","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/berh.1999.0082_RF3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.0954-6820.1975.tb04897.x","article-title":"Intrauterine death and circulating anticoagulant (\u2018antithromboplastin\u2019)","volume":"197","author":"Nilsson","year":"1975","journal-title":"Acta Medica Scandinavica"},{"key":"10.1053\/berh.1999.0082_RF4","first-page":"859","article-title":"Avortements \u00e0 r\u00e9p\u00e9tition, thromboses et anticoagulant circulant anti-thromboplastine","volume":"9","author":"Soulier","year":"1980","journal-title":"Nouvelle Press M\u00e9dicale"},{"key":"10.1053\/berh.1999.0082_RF5","first-page":"738","article-title":"Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA). Standardization and quantitation of results","volume":"62","author":"Loizou","year":"1985","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1053\/berh.1999.0082_RF6","first-page":"486","article-title":"The anticardiolipin syndrome","volume":"13","author":"Hughes","year":"1986","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0082_RF7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(83)91267-9","article-title":"Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus","volume":"ii","author":"Harris","year":"1983","journal-title":"Lancet"},{"key":"10.1053\/berh.1999.0082_RF8","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1001\/archinte.1986.00360230069012","article-title":"Thrombosis, recurrent fetal loss and thrombocytopenia. Predictive value of the anticardiolipin antibody test","volume":"146","author":"Harris","year":"1986","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/berh.1999.0082_RF9","first-page":"193","article-title":"Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus","volume":"56","author":"Koike","year":"1984","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1053\/berh.1999.0082_RF10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJM198507183130304","article-title":"Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus","volume":"313","author":"Lockshin","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/berh.1999.0082_RF11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198911000-00003","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients","volume":"68","author":"Alarc\u00f3n-Segovia","year":"1989","journal-title":"Medicine"},{"key":"10.1053\/berh.1999.0082_RF12","first-page":"34","article-title":"Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies","volume":"17","author":"Lavalle","year":"1990","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0082_RF13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/096120339700600304","article-title":"Vasculitis in systemic lupus erythematosus","volume":"6","author":"Drenkard","year":"1997","journal-title":"Lupus"},{"key":"10.1053\/berh.1999.0082_RF14","first-page":"284","article-title":"Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus","volume":"20","author":"Asherson","year":"1993","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0082_RF15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.1780370418","article-title":"Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus","volume":"37","author":"Herranz","year":"1994","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.1999.0082_RF16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1749-6632.1997.tb48401.x","article-title":"Antiphospholipid antibodies in the antiphospholipid syndrome. Clinical relevance in neuropsychiatric systemic lupus erythematosus","volume":"823","author":"Alarc\u00f3n-Segovia","year":"1997","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1053\/berh.1999.0082_RF17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1046\/j.1471-4159.1998.71030946.x","article-title":"Role of caspases in N -methyl- D -aspartate-induced apoptosis in cerebrocortical neurons","volume":"71","author":"Tenneti","year":"1998","journal-title":"Journal of Neurochemistry"},{"key":"10.1053\/berh.1999.0082_RF18","first-page":"482","article-title":"Primary antiphospholipid syndrome","volume":"16","author":"Alarc\u00f3n-Segovia","year":"1989","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0082_RF19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/ard.48.5.362","article-title":"Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder","volume":"48","author":"Mackworth-Young","year":"1989","journal-title":"Annals of Rheumatic Diseases"},{"key":"10.1053\/berh.1999.0082_RF20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005792-198911000-00004","article-title":"The \u2018primary\u2019 antiphospholipid syndrome: major clinical and serological features","volume":"68","author":"Asherson","year":"1989","journal-title":"Medicine"},{"key":"10.1053\/berh.1999.0082_RF21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(94)90108-2","article-title":"Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter study of 114 patients","volume":"96","author":"Vianna","year":"1994","journal-title":"American Journal of Medicine"},{"key":"10.1053\/berh.1999.0082_RF22","first-page":"4","article-title":"S\u0131&#x0301;ndrome de antifosfol\u0131&#x0301;pido primario (SAFP). Informe inicial de 51 pacientes. Grupo Multic\u00e9ntrico de la Ciudad de M\u00e9xico","volume":"7","author":"Cardiel","year":"1992","journal-title":"Revista Mexicana de Reumatolog\u0131&#x0301;a"},{"key":"10.1053\/berh.1999.0082_RF23","series-title":"The Autoimmune Diseases","first-page":"299","article-title":"Antiphospholipid\/cofactor syndromes","author":"Alarc\u00f3n-Segovia","year":"1998"},{"key":"10.1053\/berh.1999.0082_RF24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/096120339600500102","article-title":"Will some day PAPS fade into SLE?","volume":"5","author":"Cabral","year":"1996","journal-title":"Lupus"},{"key":"10.1053\/berh.1999.0082_RF25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-0038-1657504","article-title":"Antiphospholipid antibodies: predictive value of laboratory tests","volume":"78","author":"Galli","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/berh.1999.0082_RF26","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1055\/s-0037-1614556","article-title":"The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile","volume":"81","author":"Galli","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/berh.1999.0082_RF27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0022-1759(80)90333-6","article-title":"A simple radiommunoassay to determine binding of antibodies to lipid antigens","volume":"38","author":"Smolarsky","year":"1980","journal-title":"Journal of Immunological Methods"},{"key":"10.1053\/berh.1999.0082_RF28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0049-0172(92)90021-5","article-title":"Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus","volume":"21","author":"Alarc\u00f3n-Segovia","year":"1992","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1053\/berh.1999.0082_RF29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0140-6736(90)91697-9","article-title":"Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease","volume":"336","author":"Matsuura","year":"1990","journal-title":"Lancet"},{"key":"10.1053\/berh.1999.0082_RF30","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: \u03b22-glycoprotein I (apolipoprotein H)","volume":"87","author":"McNeil","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/berh.1999.0082_RF31","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0140-6736(90)91374-J","article-title":"Anticardiolipin antibodies (ACA) are directed not to cardiolipin but to a plasma protein cofactor","volume":"335","author":"Galli","year":"1990","journal-title":"Lancet"},{"key":"10.1053\/berh.1999.0082_RF32","series-title":"Autoantibodies","first-page":"120","article-title":"Bromelain-treated erythrocyte autoantibodies","author":"Cabral","year":"1996"},{"key":"10.1053\/berh.1999.0082_RF33","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0896-8411(05)80043-5","article-title":"Hemolytic anemia related to an IgM autoantibody to phosphatidylcholine that binds in vitro to stored and to bromelain-treated erythrocytes","volume":"3","author":"Cabral","year":"1990","journal-title":"Journal of Autoimmunity"},{"key":"10.1053\/berh.1999.0082_RF34","first-page":"1369","article-title":"Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous disease","volume":"23","author":"Berard","year":"1996","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0082_RF35","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0140-6736(93)91213-6","article-title":"Crossreaction between antibodies to oxidised low-density lipoprotein and cardiolipin in systemic lupus erythematosus","volume":"341","author":"Vaarala","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/berh.1999.0082_RF36","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1172\/JCI118854","article-title":"Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein","volume":"98","author":"Horkko","year":"1996","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/berh.1999.0082_RF37","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/rheumatology\/36.9.964","article-title":"Autoantibodies against oxidized low-density lipoprotein in antiphospholipid syndrome","volume":"36","author":"Amengual","year":"1997","journal-title":"British Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0082_RF38","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/37.8.883","article-title":"Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-\u03b22-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein","volume":"37","author":"Romero","year":"1998","journal-title":"British Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0082_RF39","first-page":"396","article-title":"Anticardiolipin and anti-\u03b22-glycoprotein I immunoassays in the diagnosis of antiphospholipid syndrome","volume":"16","author":"Tincani","year":"1998","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1053\/berh.1999.0082_RF40","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4049\/jimmunol.154.2.954","article-title":"\u2018Anticardiolipin\u2019 autoantibodies recognize \u03b22-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding","volume":"154","author":"Roubey","year":"1995","journal-title":"Journal of Immunology"},{"key":"10.1053\/berh.1999.0082_RF41","first-page":"1894","article-title":"Antibodies to phospholipid-free \u03b22-glycoprotein-I in the serum of patients with primary antiphospholipid syndrome","volume":"22","author":"Cabral","year":"1995","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0082_RF42","first-page":"1899","article-title":"Clinical manifestations of the antiphospholipid syndrome in systemic lupus erythematosus patients associate more strongly with anti-\u03b22-glycoprotein-I than with antiphospholipid antibodies","volume":"22","author":"Cabiedes","year":"1995","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0082_RF43","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0002-9343(96)00254-9","article-title":"The antiphospholipid\/cofactor syndromes. A primary variant with antibodies to \u03b22-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays","volume":"101","author":"Cabral","year":"1996","journal-title":"American Journal of Medicine"},{"key":"10.1053\/berh.1999.0082_RF44","first-page":"1545","article-title":"The antiphospholipid\/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to \u03b22-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays","volume":"24","author":"Alarc\u00f3n-Segovia","year":"1997","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0082_RF45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0002-9343(99)00053-4","article-title":"Serum anti-\u03b22-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients","volume":"106","author":"G\u00f3mez-Pacheco","year":"1999","journal-title":"American Journal of Medicine"},{"key":"10.1053\/berh.1999.0082_RF46","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1182\/blood.V72.2.512.512","article-title":"Anti-prothrombin antibodies and the lupus anticoagulant","volume":"72","author":"Fleck","year":"1988","journal-title":"Blood"},{"key":"10.1053\/berh.1999.0082_RF47","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1055\/s-0038-1649891","article-title":"Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants","volume":"74","author":"Arvieux","year":"1995","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/berh.1999.0082_RF48","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/blood.V93.7.2149","article-title":"Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome","volume":"93","author":"Galli","year":"1999","journal-title":"Blood"},{"key":"10.1053\/berh.1999.0082_RF49","first-page":"1319","article-title":"Antiphospholipid\/cofactor syndromes","volume":"23","author":"Alarc\u00f3n-Segovia","year":"1996","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0082_RF50","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/096120339700600908","article-title":"Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies","volume":"6","author":"George","year":"1997","journal-title":"Lupus"},{"key":"10.1053\/berh.1999.0082_RF51","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.99.17.2227","article-title":"Immunolocalization of \u03b22-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression","volume":"99","author":"George","year":"1999","journal-title":"Circulation"},{"key":"10.1053\/berh.1999.0082_RF52","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0002-9343(92)90264-C","article-title":"Decrease in serum antiphospholipid antibody levels upon development of nephrotic syndrome in patients with systemic lupus erythematosus: relationship to urinary loss of IgG and other factors","volume":"92","author":"P\u00e9rez Vazquez","year":"1992","journal-title":"American Journal of Medicine"},{"key":"10.1053\/berh.1999.0082_RF53","first-page":"113","article-title":"Anticardiolipin (aCL) and anti-\u03b22-glycoprotein-I (anti-\u03b22GP-I) in hypertensive disorders of pregnancy","volume":"7","author":"Vald\u00e9s-Macho","year":"1998","journal-title":"Lupus"},{"key":"10.1053\/berh.1999.0082_RF54","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an International Workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis and Rheumatism"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694299900827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694299900827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T23:30:15Z","timestamp":1682292615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694299900827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S1521694299900827"],"URL":"https:\/\/doi.org\/10.1053\/berh.1999.0082","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}